Lingzhen Wu

Low serum adropin is associated with coronary atherosclerosis in type 2 diabetic and non-diabetic patients

Lingzhen Wu, Jun Fang, Lianglong Chen et al. · Clinical Chemistry and Laboratory Medicine (CCLM) · 2013 · 158 citations

Medicine, Cardiology, Endocrinology +16

Pharmacological postconditioning with tanshinone IIA attenuates myocardial ischemia-reperfusion injury in rats by activating the phosphatidylinositol 3-kinase pathway

Xun Yuan, Songbo Jing, Lingzhen Wu et al. · Experimental and Therapeutic Medicine · 2014 · 46 citations · Full text

Medicine, Cardiology, Pharmacology +13

Serum fetuin-A levels are associated with the presence and severity of coronary artery disease in patients with type 2 diabetes

Ziwen Zhao, Chaogui Lin, Lingzhen Wu et al. · Biomarkers · 2013 · 44 citations

Medicine, Cardiology, Endocrinology +16

Adropin-based dual treatment enhances the therapeutic potential of mesenchymal stem cells in rat myocardial infarction

Huiya Li, Danqing Hu, Guilin Chen et al. · Cell Death and Disease · 2021 · 33 citations · Full text

Life Sciences, Cardiology, Cell Biology +10

N,N-dimethylsphingosine attenuates myocardial ischemia–reperfusion injury by recruiting regulatory T cells through PI3K/Akt pathway in mice

Jun Fang, Fudong Hu, Dan Ke et al. · Basic Research in Cardiology · 2016 · 29 citations

Life Sciences, Molecular Biology, Pharmacology +13